The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 32,179,141 | 446,127 | SH | SOLE | 0 | 446,127 | 0 | 0 | |
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 122,133,194 | 668,710 | SH | SOLE | 0 | 668,710 | 0 | 0 | |
| CIDARA THERAPEUTICS INC | COM NEW | 171757206 | 1,022,721 | 4,630 | SH | SOLE | 0 | 4,630 | 0 | 0 | |
| IMMUNEERING CORP | CLASS A COM | 45254E107 | 150,912 | 22,935 | SH | SOLE | 0 | 22,935 | 0 | 0 | |
| INVESCO EXCHANGE TRADED FD T | S&P500 EQL UTL | 46137V274 | 212,899 | 2,847 | SH | SOLE | 0 | 2,847 | 0 | 0 | |
| ISHARES TR | 20 YR TR BD ETF | 464287432 | 2,015,401 | 23,123 | SH | SOLE | 0 | 23,123 | 0 | 0 | |
| KURA ONCOLOGY INC | COM | 50127T109 | 14,781,666 | 1,422,682 | SH | SOLE | 0 | 1,422,682 | 0 | 0 | |
| OPEN LENDING CORP | COM | 68373J104 | 18,600 | 12,000 | SH | SOLE | 0 | 12,000 | 0 | 0 | |
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 9,497,100 | 13,927 | SH | SOLE | 0 | 13,927 | 0 | 0 | |
| SPDR SERIES TRUST | STATE STREET SPD | 78468R663 | 21,621,505 | 236,611 | SH | SOLE | 0 | 236,611 | 0 | 0 | |
| TASEKO MINES LTD | COM | 876511106 | 56,600 | 10,000 | SH | SOLE | 0 | 10,000 | 0 | 0 | |
| TEMPUS AI INC | CL A | 88023B103 | 1,863,264 | 31,554 | SH | SOLE | 0 | 31,554 | 0 | 0 | |
| WISDOMTREE TR | EUROPE HEDGED EQ | 97717X701 | 394,236 | 7,430 | SH | SOLE | 0 | 7,430 | 0 | 0 | |